
EP009
CAS No. 1462951-30-9
EP009( EP-009 | EP 009 )
Catalog No. M11987 CAS No. 1462951-30-9
A selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEP009
-
NoteResearch use only, not for human use.
-
Brief DescriptionA selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM.
-
DescriptionA selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM; exhibits limited off-target effects against a panel of 92 human kinases; inhibits tyrosine phosphorylation and activation of JAK3/STAT3 in SU-DHL-1 cells, with activation of JNK1/2, but not p38; displays a favorable cytotoxicity profile with therapeutic efficacy against JAK3-driven tumor T-cells in vitro, in vivo, and ex vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsEP-009 | EP 009
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1462951-30-9
-
Formula Weight224.344
-
Molecular FormulaC14H24O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(CO)CCCCCCCCCC1=C
-
Chemical Name2-(hydroxymethyl)-12-methylenecyclododecanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ross JA, et al. Leukemia. 2014 Apr;28(4):941-4.
2. Martinez GS, et al. Clin Cancer Drugs. 2016;3(2):131-137.
molnova catalog



related products
-
GLPG-0634
A potent JAK1/JAK2 inhibitor with IC50 of 10 nM/28 nM in biochemical assays; less potent for JAK3 and TYK2.
-
Tyk2-IN-30
TYK2-IN-30 is a potent, selective and orally active Tyk2 inhibitor with Ki of 0.7 nM.
-
ZT55
ZT55 (JAK inhibitor ZT55) is a novel potent, highly-selective tyrosine kinase JAK2 inhibitor with IC50 of 31 nM.